Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.
Publication
, Journal Article
McSwain, ML; Forman, LM
Published in: J Clin Psychopharmacol
August 1995
Duke Scholars
Published In
J Clin Psychopharmacol
DOI
ISSN
0271-0749
Publication Date
August 1995
Volume
15
Issue
4
Start / End Page
284
Location
United States
Related Subject Headings
- Tacrine
- Psychiatry
- Parkinson Disease, Secondary
- Nootropic Agents
- Male
- Humans
- Haloperidol
- Drug Therapy, Combination
- Dementia
- Antipsychotic Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
McSwain, M. L., & Forman, L. M. (1995). Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol. J Clin Psychopharmacol, 15(4), 284. https://doi.org/10.1097/00004714-199508000-00008
McSwain, M. L., and L. M. Forman. “Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.” J Clin Psychopharmacol 15, no. 4 (August 1995): 284. https://doi.org/10.1097/00004714-199508000-00008.
McSwain ML, Forman LM. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol. J Clin Psychopharmacol. 1995 Aug;15(4):284.
McSwain, M. L., and L. M. Forman. “Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol.” J Clin Psychopharmacol, vol. 15, no. 4, Aug. 1995, p. 284. Pubmed, doi:10.1097/00004714-199508000-00008.
McSwain ML, Forman LM. Severe parkinsonian symptom development on combination treatment with tacrine and haloperidol. J Clin Psychopharmacol. 1995 Aug;15(4):284.
Published In
J Clin Psychopharmacol
DOI
ISSN
0271-0749
Publication Date
August 1995
Volume
15
Issue
4
Start / End Page
284
Location
United States
Related Subject Headings
- Tacrine
- Psychiatry
- Parkinson Disease, Secondary
- Nootropic Agents
- Male
- Humans
- Haloperidol
- Drug Therapy, Combination
- Dementia
- Antipsychotic Agents